![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_d5fdcbd64ce08d55a205958f457a3eae.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 3.7 [1], 4300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_aa00458f1467647d20b3007e61bac6f9.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 5.0 [1], 5810.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_6ad7fb41103afcfb6d392347cc2a3ba8.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-methylamino]-3-[[(2S)-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]hexanoyl]amino]-4-oxobutanoic acid | IC50 | 4.2 [1], 710.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_57d2edeab63967815ad7a3ef4a8991f4.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-6-[[(E)-3-pyridin-3-ylprop-2-enoyl]amino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 41.0 [1], 10400.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_4841fada4c723b9c72b2abdd4afacc7d.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-methylamino]-3-[[(2S)-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 9.0 [1], 13600.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_ebf8ab17058df71d0658b14326113f84.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-methylamino]-3-[[(2S)-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-6-[[(E)-3-thiophen-2-ylprop-2-enoyl]amino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 32.0 [1], 10900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_29dc8ed78b4d477fe614b33a716a6b37.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-6-[[(E)-3-thiophen-2-ylprop-2-enoyl]amino]hexanoyl]-methylamino]-4-oxobutanoic acid | IC50 | 35.0 [1], 4577.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_90299095f1a4e3d3c2029dff8987a74f.svg) | (3S)-4-[[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-methylamino]-3-[[(2S)-2-[[3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-6-[[(E)-3-thiophen-2-ylprop-2-enoyl]amino]hexanoyl]amino]-4-oxobutanoic acid | IC50 | 18.0 [1], 731.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_7903bd2d1c6893b8465dc90acb9c0c40.svg) | Diazepam | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_8c17699dd6a8601a97ee28fed7c9da3c.svg) | Clonazepam | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_4810256f3afb016bfb452d70e25e333f.svg) | Chlordiazepoxide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_5172f44ff113535835c74fffc2a5e8e3.svg) | Flunitrazepam | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_71f4d08af1c8dcbf1fddf9ff6b16b69e.svg) | Devazepide | IC50 | 270.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_25f5e25b0dad5fba18d7a0a972a7ad5f.svg) | Naluzotan | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_149fad94db669ea8efd8476c130b1288.svg) | Cholecystokinin (27-33), tert-butyloxycarbonyl-nle(28,31)- | IC50 | 0.3 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_48438bcceb431b41622ad25f9534185d.svg) | Devazepida | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_ee48b92e267700c6d8fc41fe5e26c1ab.svg) | 1-Methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_d0ae2ec628d684735ce55c7d92a514ce.svg) | 5-(2-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_89463df6998f7fba414ca97119581d32.svg) | 1-Methyl-3-(4-bromobenzoyl)amino-5-phenyl-3H-1,4-benzodiazepin-2-one | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_eb0905d6ed7d1b0958f069889857b410.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_fbcb609fc5d7cf47804e5eeae6313b92.svg) | N-[(3R)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 3700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_552329349547da24b38110a91c8c1461.svg) | 4-Chloro-N-[(3S)-5-(2-fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]benzamide | IC50 | 2900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_d921b3edefc65a841cadae3067c954b3.svg) | Ethyl 2-[3-[(4-chlorobenzoyl)amino]-5-(2-fluorophenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate | IC50 | 1900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_3e3173232e941f7895629ba9263bad0f.svg) | 2-(1H-Indol-3-yl)-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-acetamide | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_9d5af0fd6ddd4039cfb2f7f0678968d1.svg) | N-[5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_608cc85e4311c8bdf998008589c05329.svg) | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_8966a4c8418d6b899fe3fd264f020bed.svg) | 4-Chloro-N-[(3R)-5-(2-fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]benzamide | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_f64dfecea1f30d7e57114a1de6b33b89.svg) | 4-Chloro-N-[5-(2-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_9acb253416f0c78bdde441b78637416b.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_d832bb559452f08d1d3323e434ccb1b0.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-1H-indole-3-carboxamide | IC50 | 8400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_046f7bae769f065cacebc628b2f63510.svg) | 3-(1H-Indol-3-yl)-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_b7c3776baf40b107cec040be00f88abb.svg) | 4-(1H-Indol-3-yl)-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)butanamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_6dc0664640ad6adf44c2763059bd8366.svg) | 4-Chloro-N-[5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_ba689c8e642c26603639d9af0c405d05.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]quinazoline-2-carboxamide | IC50 | 80000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_74e3e4c27b4da622bf0fe16159844d11.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1-benzofuran-2-carboxamide | IC50 | 32000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_96a552008cc45ea52d70a0879f4a9e56.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-pyrrole-2-carboxamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_6924c493b35f84f0aa5a774b4bddb93d.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)naphthalene-2-carboxamide | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_e6ea538f28d6886903f96c4a1f0a4023.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)naphthalene-1-carboxamide | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_3f00bb0206832b4f0003922c146d0e3e.svg) | N-[(3S)-5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_c6d09b92ed0a1018fc47e6cf0864712a.svg) | N-[5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-1-methylindole-2-carboxamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_f94810d7400695a5fdef53fb73b1e95e.svg) | 5-Fluoro-N-[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_8de0f900608f1563dc0df4b56ee4601d.svg) | 5-Chloro-N-[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 38000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_6e269ad733cf4f036a5e9c40546e19b9.svg) | 1-Methyl-N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)indole-2-carboxamide | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_bd8a5ac067d53912d89183951002c8ff.svg) | 5-Bromo-N-[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_2867446d5683ac22a36a087e75160c25.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-5-hydroxy-1H-indole-2-carboxamide | IC50 | 16000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_54cc1121593619718234b806b5064136.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-5-methoxy-1H-indole-2-carboxamide | IC50 | 29000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_489d1c6f123e7640291d164aded5ef4c.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-1-methylindole-2-carboxamide | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_68f18bb8afd2086023db0dda7a0122d9.svg) | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-nitro-benzamide | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_aa43d1a9fc6407bbd7ea3759da3553c4.svg) | 4-Chloro-N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_456a8d0a8653dcec97e689f3b759bc11.svg) | 4-Chloro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_c19a9eb973ce178f4c83c22d9b421fd7.svg) | 2-Chloro-N-[5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_bc7e7d1089f8ea463f6cf5a536fb2101.svg) | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-trifluoromethyl-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_b12766ccd7dda95c426162807f3a4c81.svg) | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-methyl-benzamide | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_33d3e055d8e523ca8dd942154d441bdb.svg) | 2-Chloro-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_30ce054961b9eabaa1275cc8741f41ac.svg) | 2-Chloro-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide | IC50 | 83000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_966f54c84f57cb3c08baabc757819859.svg) | 3-Chloro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 75000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_ba0fca3b81bd123c0687ce23edea855b.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-4-methoxybenzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_2df09e1427a2075a5c4b24bcf47bc2aa.svg) | 4-Dimethylamino-N-[5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_d2cb78746134e7ab1e60c00157dcd41d.svg) | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3,4-dimethoxy-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_597e63031fc6d006f9c3d700c28b4576.svg) | 4-Fluoro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 43000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_896bac8549ef84103792191412cd9a3c.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-4-(trifluoromethyl)benzamide | IC50 | 65000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_04142cbe6b727c28078850842f73a92c.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-4-phenylbenzamide | IC50 | 18000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_1e9cd72d26577643ffe566d0649ea96f.svg) | 4-Tert-Butyl-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_3ac0f447622a9a17644e1b0f211683dc.svg) | 3,5-Dichloro-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_8315a88bb20c7b0209b01d55d5d6d9e2.svg) | 4-Hydroxy-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_6dbdf7263de008f18efcdbfce0e5eedf.svg) | 4-Cyano-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_bc9f51ed66ecfb7c68e590734b100ce0.svg) | 2-Amino-4-chloro-N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)benzamide | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_11c9f06fd83cf2cf26edf273fe176e34.svg) | 4-Bromo-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide | IC50 | 1600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_c794a4eb6a369a1de252cf6ebfb7da4b.svg) | N-[5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-4-(trifluoromethyl)benzamide | IC50 | 1800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_06eeec0998c5cc841079c5a7523080f7.svg) | N-[(3S)-5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-4-(trifluoromethyl)benzamide | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_70d4073329255c6d24bacee760c7757f.svg) | 4-Tert-butyl-N-[5-(2-fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]benzamide | IC50 | 2300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_f4904704d0867628f6b7b85c43be0400.svg) | 4-Tert-butyl-N-[(3S)-5-(2-fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]benzamide | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_7336811d250bdac28531c9e9d4e1ab2a.svg) | N-[5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-3-iodobenzamide | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_dd72fdcb353d049eb9e7b3f044ac8a23.svg) | N-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-4-pentylbenzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_304dc1516dbe66fcba7fa64ac7fa8215.svg) | N-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-4-(trifluoromethyl)benzamide | IC50 | 4600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_5c38a68ef73780e5406f280de726c569.svg) | (3R)-1-Methyl-3-[[4-(trifluoromethyl)benzoyl]amino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one | IC50 | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_c6fd42cdef9626f1966fe728e3aad090.svg) | Ethyl 2-[3-[(2-chlorobenzoyl)amino]-5-(2-fluorophenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate | IC50 | 3200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_e65f0560324d91e9c19b02153bb1edb9.svg) | (2R)-2-Amino-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_3ea417dfdf2fb5ed91bcef4f718dfcdb.svg) | 3,4-Dichloro-N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_125b62351fa7d4278f89c84b2a8879e0.svg) | 2-Chloro-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)benzamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_5f6e8cb9e005b8fb1f25f2cc6e14b250.svg) | 4-Methylsulfanyl-N-(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)benzamide | IC50 | 23000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_9f509ce66c71025050eb58f914161550.svg) | 7-Chloro-3-(1H-indol-3-ylmethyl)-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_13cf37d873b191264482a68662c326dd.svg) | N-[5-(2-Fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-4-pentyl-benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_45ce5332a7d7e1ec77463595a32447eb.svg) | 1-[4-[4-[2-Tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]butyl]-3,4-dihydro-1-benzazepine-2,5-dione | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_9a925a108f3920826f9bc4a2c3a3232b.svg) | Ethyl 2-[[(3R)-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-2-ylidene]amino]acetate | IC50 | 49000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_1441eac3ac3e2abff6ee869db27b9a89.svg) | 2-[[(3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-1,3-dihydro-1,4-benzodiazepin-2-ylidene]amino]acetic acid | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_41ecf2ed78ca3ee8e55a0632ef431db7.svg) | (3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-N-methyl-1,3-dihydro-1,4-benzodiazepin-2-imine | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_6ecb16aaf7e9e8cdd280446a31bb986f.svg) | 2-[(3R)-3-(1H-Indol-3-ylmethyl)-2-methylimino-1,3-dihydro-1,4-benzodiazepin-5-yl]-N-methylaniline | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_661442c3317e10d6a566c06463eaebe2.svg) | (3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-N-propyl-1,3-dihydro-1,4-benzodiazepin-2-imine | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_359c377717caebfa2931b04264adee81.svg) | Tert-butyl N-[(2R)-1-[(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]carbamate | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_5679c943985de7c09caa56afef0f468d.svg) | (2R)-2-Amino-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_9f5574640236a43c8a6a52600f4f5958.svg) | (3R)-5-(2-Fluorophenyl)-3-(1H-indol-3-ylmethyl)-N-phenyl-3H-1,4-benzodiazepin-2-amine | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_8adf51963466214d655caf905717e626.svg) | Tert-butyl N-[(2S)-3-(1H-indol-3-yl)-1-oxo-1-[(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)amino]propan-2-yl]carbamate | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_72e36cdad52ffd6964626222b3ad4d06.svg) | Tert-butyl N-[(2R)-3-(1H-indol-3-yl)-1-oxo-1-[(2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)amino]propan-2-yl]carbamate | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_c431df6ba18e80caadde044b15332555.svg) | 2-(1-Benzothiophen-4-yl)-N-[5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]acetamide | IC50 | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_5b2ee11016c5d64e2df4d74fc55a1970.svg) | N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-hydroxy-2-phenylacetamide | IC50 | 80000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_f8207f04c342ea83d576461e20977630.svg) | (E)-N-[5-(2-Fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-phenylprop-2-enamide | IC50 | 5500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_9c156ec559ca83d59fe5fae023ce7af4.svg) | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-acetamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_95c15dfed9d1d0674caa109c4eeeab7d.svg) | N-(2-Oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-2,3-dihydro-1H-indole-2-carboxamide | IC50 | 40000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cholecystokinin-receptor_5d5c6c1287bdac3a90ca851eec8491b3.svg) | N-[5-(2-Fluorophenyl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]thiophene-3-carboxamide | IC50 | 26000.0 [1] |